NCT04294641 2026-01-23
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
9 trialsNCT05599347 2025-04-04
AZITRATIM
Rambam Health Care Campus
Phase 2 Recruiting
NCT06207786 2024-11-25
Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery
Mayo Clinic
Phase NA Withdrawn
NCT02517099 2023-03-06
PrIGMa
Imperial College London
Phase 2 Completed
NCT04394182 2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA Suspended
NCT04392128 2020-09-04
HYACINTHE
Institut de cancérologie Strasbourg Europe
Phase 2 Withdrawn
NCT04454151 2020-07-01
FAP
Tel-Aviv Sourasky Medical Center
Phase 4 Unknown
NCT04341207 2020-04-10
ONCOVID
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Unknown
NCT00644176 2011-06-08
A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery
Pfizer
Phase 2 Completed